HOME



Digby's Hullabaloo
2801 Ocean Park Blvd.
Box 157
Santa Monica, Ca 90405



Facebook: Digby Parton

Twitter:
@digby56
@Gaius_Publius
@BloggersRUs (Tom Sullivan)
@spockosbrain



emails:
Digby:
thedigbyblog at gmail
Dennis:
satniteflix at gmail
Gaius:
publius.gaius at gmail
Tom:
tpostsully at gmail
Spocko:
Spockosbrain at gmail
tristero:
Richardein at me.com








Infomania

Salon
Buzzflash
Mother Jones
Raw Story
Huffington Post
Slate
Crooks and Liars
American Prospect
New Republic
Common Dreams
AmericanPoliticsJournal
Smirking Chimp
CJR Daily
consortium news

Blog-o-rama

Eschaton
BagNewsNotes
Daily Kos
Political Animal
Driftglass
Firedoglake
Taylor Marsh
Spocko's Brain
Talk Left
Suburban Guerrilla
Scoobie Davis
Echidne
Electrolite
Americablog
Tom Tomorrow
Left Coaster
Angry Bear
oilprice.com
Seeing the Forest
Cathie From Canada
Frontier River Guides
Brad DeLong
The Sideshow
Liberal Oasis
BartCop
Juan Cole
Rising Hegemon
alicublog
Unqualified Offerings
Alas, A Blog
RogerAiles
Lean Left
Oliver Willis
skippy the bush kangaroo
uggabugga
Crooked Timber
discourse.net
Amygdala
the talking dog
David E's Fablog
The Agonist


Denofcinema.com: Saturday Night at the Movies by Dennis Hartley review archive

01/01/2003 - 02/01/2003 02/01/2003 - 03/01/2003 03/01/2003 - 04/01/2003 04/01/2003 - 05/01/2003 05/01/2003 - 06/01/2003 06/01/2003 - 07/01/2003 07/01/2003 - 08/01/2003 08/01/2003 - 09/01/2003 09/01/2003 - 10/01/2003 10/01/2003 - 11/01/2003 11/01/2003 - 12/01/2003 12/01/2003 - 01/01/2004 01/01/2004 - 02/01/2004 02/01/2004 - 03/01/2004 03/01/2004 - 04/01/2004 04/01/2004 - 05/01/2004 05/01/2004 - 06/01/2004 06/01/2004 - 07/01/2004 07/01/2004 - 08/01/2004 08/01/2004 - 09/01/2004 09/01/2004 - 10/01/2004 10/01/2004 - 11/01/2004 11/01/2004 - 12/01/2004 12/01/2004 - 01/01/2005 01/01/2005 - 02/01/2005 02/01/2005 - 03/01/2005 03/01/2005 - 04/01/2005 04/01/2005 - 05/01/2005 05/01/2005 - 06/01/2005 06/01/2005 - 07/01/2005 07/01/2005 - 08/01/2005 08/01/2005 - 09/01/2005 09/01/2005 - 10/01/2005 10/01/2005 - 11/01/2005 11/01/2005 - 12/01/2005 12/01/2005 - 01/01/2006 01/01/2006 - 02/01/2006 02/01/2006 - 03/01/2006 03/01/2006 - 04/01/2006 04/01/2006 - 05/01/2006 05/01/2006 - 06/01/2006 06/01/2006 - 07/01/2006 07/01/2006 - 08/01/2006 08/01/2006 - 09/01/2006 09/01/2006 - 10/01/2006 10/01/2006 - 11/01/2006 11/01/2006 - 12/01/2006 12/01/2006 - 01/01/2007 01/01/2007 - 02/01/2007 02/01/2007 - 03/01/2007 03/01/2007 - 04/01/2007 04/01/2007 - 05/01/2007 05/01/2007 - 06/01/2007 06/01/2007 - 07/01/2007 07/01/2007 - 08/01/2007 08/01/2007 - 09/01/2007 09/01/2007 - 10/01/2007 10/01/2007 - 11/01/2007 11/01/2007 - 12/01/2007 12/01/2007 - 01/01/2008 01/01/2008 - 02/01/2008 02/01/2008 - 03/01/2008 03/01/2008 - 04/01/2008 04/01/2008 - 05/01/2008 05/01/2008 - 06/01/2008 06/01/2008 - 07/01/2008 07/01/2008 - 08/01/2008 08/01/2008 - 09/01/2008 09/01/2008 - 10/01/2008 10/01/2008 - 11/01/2008 11/01/2008 - 12/01/2008 12/01/2008 - 01/01/2009 01/01/2009 - 02/01/2009 02/01/2009 - 03/01/2009 03/01/2009 - 04/01/2009 04/01/2009 - 05/01/2009 05/01/2009 - 06/01/2009 06/01/2009 - 07/01/2009 07/01/2009 - 08/01/2009 08/01/2009 - 09/01/2009 09/01/2009 - 10/01/2009 10/01/2009 - 11/01/2009 11/01/2009 - 12/01/2009 12/01/2009 - 01/01/2010 01/01/2010 - 02/01/2010 02/01/2010 - 03/01/2010 03/01/2010 - 04/01/2010 04/01/2010 - 05/01/2010 05/01/2010 - 06/01/2010 06/01/2010 - 07/01/2010 07/01/2010 - 08/01/2010 08/01/2010 - 09/01/2010 09/01/2010 - 10/01/2010 10/01/2010 - 11/01/2010 11/01/2010 - 12/01/2010 12/01/2010 - 01/01/2011 01/01/2011 - 02/01/2011 02/01/2011 - 03/01/2011 03/01/2011 - 04/01/2011 04/01/2011 - 05/01/2011 05/01/2011 - 06/01/2011 06/01/2011 - 07/01/2011 07/01/2011 - 08/01/2011 08/01/2011 - 09/01/2011 09/01/2011 - 10/01/2011 10/01/2011 - 11/01/2011 11/01/2011 - 12/01/2011 12/01/2011 - 01/01/2012 01/01/2012 - 02/01/2012 02/01/2012 - 03/01/2012 03/01/2012 - 04/01/2012 04/01/2012 - 05/01/2012 05/01/2012 - 06/01/2012 06/01/2012 - 07/01/2012 07/01/2012 - 08/01/2012 08/01/2012 - 09/01/2012 09/01/2012 - 10/01/2012 10/01/2012 - 11/01/2012 11/01/2012 - 12/01/2012 12/01/2012 - 01/01/2013 01/01/2013 - 02/01/2013 02/01/2013 - 03/01/2013 03/01/2013 - 04/01/2013 04/01/2013 - 05/01/2013 05/01/2013 - 06/01/2013 06/01/2013 - 07/01/2013 07/01/2013 - 08/01/2013 08/01/2013 - 09/01/2013 09/01/2013 - 10/01/2013 10/01/2013 - 11/01/2013 11/01/2013 - 12/01/2013 12/01/2013 - 01/01/2014 01/01/2014 - 02/01/2014 02/01/2014 - 03/01/2014 03/01/2014 - 04/01/2014 04/01/2014 - 05/01/2014 05/01/2014 - 06/01/2014 06/01/2014 - 07/01/2014 07/01/2014 - 08/01/2014 08/01/2014 - 09/01/2014 09/01/2014 - 10/01/2014 10/01/2014 - 11/01/2014 11/01/2014 - 12/01/2014 12/01/2014 - 01/01/2015 01/01/2015 - 02/01/2015 02/01/2015 - 03/01/2015 03/01/2015 - 04/01/2015 04/01/2015 - 05/01/2015 05/01/2015 - 06/01/2015 06/01/2015 - 07/01/2015 07/01/2015 - 08/01/2015 08/01/2015 - 09/01/2015 09/01/2015 - 10/01/2015 10/01/2015 - 11/01/2015 11/01/2015 - 12/01/2015 12/01/2015 - 01/01/2016 01/01/2016 - 02/01/2016 02/01/2016 - 03/01/2016 03/01/2016 - 04/01/2016 04/01/2016 - 05/01/2016 05/01/2016 - 06/01/2016 06/01/2016 - 07/01/2016 07/01/2016 - 08/01/2016 08/01/2016 - 09/01/2016 09/01/2016 - 10/01/2016 10/01/2016 - 11/01/2016 11/01/2016 - 12/01/2016 12/01/2016 - 01/01/2017


 

This page is powered by Blogger. Isn't yours?

Hullabaloo


Wednesday, August 31, 2016

 
Mylan didn't lower EpiPen Prices — they just appeared to

by Gaius Publius


These days have seen a number of stories about the Mylan EpiPen scandal, the essence of which is captured in the graphic at the top (note, though, that the graphic understates the EpiPen price; it's now around $640). Heather Bresch, Mylan's CEO, decided to increase corporate profit by increasing the price of a mature product, EpiPen, a device that delivers life-saving epinephrine to people who suffer life-threatening anaphylactic shock from allergic exposure to, for example, bee stings and peanuts.

In the view of most observers, she did it simply because she could.


West Virginia Democratic Senator Joe Manchin's daughter Heather Bresch, CEO of Mylan, and some of the work she's been doing. Note — the EpiPen price is actually around $640 at most pharmacies (source).


There's no economic reason for the price increases, any of them. Epinephrine (basically adrenalin) is not proprietary. As Dr. Lee Rogers notes in the first link below, "As a hormone, it's a product of nature and cannot be patented." And the delivery mechanism (the "pen") has been around since 1977. All of the R&D is done, and the medicine is cheap. All told, each EpiPen contains just one dollar worth of medicine. (And it seems the original EpiPen was at least partly developed with taxpayer money.)

Yet under Heather Bresch, Mylan has steadily raised the price from about $50, its price when Mylan acquired the 50-year-old product, to more than $600 — because they could. In 2009, the year Bresch became president, the price of the EpiPen was increased 19%, followed by 10% hikes each year from 2010 through 2013. Then:
After successfully pushing for legislation requiring all public schools to carry emergency epinephrine [devices], Mylan jacked up the price by 15 percent every other quarter from the end of 2013 to the second quarter of 2016 [emphasis mine].
And that's how the game is played.

A shakedown scheme with a sidecar of murder

As I noted here, this is basically a shakedown scheme with a sidecar of murder — "Got a peanut allergy? Pay my new price or the kid dies." In the meantime, corporate profit went through the roof, as did CEO compensation, as the graphic shows.

Dr. Lee Rogers, a medical doctor and former progressive House candidate, broke the story at DownWithTyranny:


There's a good follow-up here:


Two side wrinkles and you're up to date:

First, CEO Bresch may have engaged in insider trading when she sold over 100,000 shares of Mylan stock in advance of the latest price increases. As noted in the second link above, the stock price fell drastically after Dr. Rogers' piece was published.

Second, Bresch has taken Mylan through a corporate "inversion," a scheme by which a U.S. company buys a foreign subsidiary, then becomes a foreign corporation, with nothing else changing but its U.S. tax status. LA Times reporter Michael Hiltzik has written a full report on Mylan's inversion here.

Shamed by the scandal, Heather Bresch pretended to lower EpiPen's price

Mylan's price-gouging on its EpiPen business is indeed a scandal, not just on the business pages because of the sudden stock decline, but in the larger press because of the "vulture CEO" angle. Even MSNBC, which tends to keep hands off of Democrats, covered it, and tagged Sen. Joe Manchin in the story. (For more on Manchin and his responsibility for his daughter's career, do read Dr. Rogers' well researched story. Manchin's been involved at almost every stage of it.)

As a result of the horrible press, Mylan responded. It was initially reported that Mylan would lower the price of its EpiPen package by 50% in response to public outrage. For example, from The Hill:
EpiPen maker lowers price after uproar

The maker of EpiPens announced Thursday that it is reducing the price of the device following an uproar in Washington over the cost of the treatment for serious allergic reactions.

Mylan, the company that makes EpiPen, said it will provide a savings card worth up to $300 for people who had been paying the full price out-of-pocket, effectively reducing the cost by 50 percent.

The company is also making it easier to qualify for its patient assistance program, which eliminates out-of-pocket costs for uninsured and underinsured people....

Mylan announced the changed a day after Hillary Clinton denounced the company for hiking the cost of EpiPens 400 percent in recent years. Lawmakers on Capitol Hill had also sounded the alarm, sending letters to the company and to the Food and Drug Administration pressing for answers.

Mylan also pointed to insurance companies in its Thursday statement, noting that higher deductibles have left patients picking up more of the cost of drugs like EpiPens.
I hope you noted that last sentence, in which Mylan says "higher deductibles have left patients picking up more of the cost of drugs like EpiPens." Remember, each EpiPen contains about $1 worth of medicine. Patients are actually picking up the cost of CEO Bresch's nearly 700% compensation increase.

But it didn't take long for that "50% reduction in cost" claim to be more carefully looked at. For example, from USuncut:
EpiPen did not actually lower their price — it’s just another Pharma scam

Mylan Pharmaceuticals is now running a slick PR campaign to try and convince Americans they lowered the price of the EpiPen. Don’t buy it.

On Thursday morning, it was widely reported that Mylan responded to consumer outrage by lowering the price of the drug by 50 percent. While that may be true on the surface, the company didn’t actually change the price at all. The drug company’s rollout of EpiPen price cuts only applies to uninsured and underinsured consumers, who are given a $300 savings card while still having to pay roughly $300 more for a [$640] package of two EpiPens.
The bottom line?
However, the market price of the EpiPen remains the same.
And that's how the game is played.

This is Heather Manchin Bresch, by the way, in case you see her on the street. I'm sure she'd be glad to explain the numerous price increases at length. Maybe there's a nuance she can point you to that I've missed.


Mylan CEO Heather Bresch (source; photo credit Joe Wojcik)


Or maybe not. This really is shakedown scheme, with a sidecar of "or your kid dies." Is predator too strong a word for this behavior? Or is predation just business as usual in drug company CEO suites and the DC political offices that take their money?

Hate the drug companies? Support California's Prop 61 in November

If you think predator is not too strong a word for drug company "shakedown or death" profit schemes, consider supporting California's new Proposition 61, which will end Big Pharma's hold on unchecked and sky-high prices. Prop 61 is a serious attack on drug pricing, and it will work if it's passed. It will also appear in a number of other states if it's passed — hope for us all.

More on Prop 61 here.

(A version of this piece appeared at Down With Tyranny. GP article archive here.)

GP
 

.